[Prevalence and importance of endoparasites in calves raised in Swiss cow-calf farms].

A longitudinal study was performed to establish estimates of prevalence of selected endoparasites in Swiss cow-calf operations and to investigate the importance of an infection with endoparasites on diarrhea and weight gain until weaning. Three hundred and eighty-six calves raised in 67 larger cow-calf herds were included in the study. Faecal samples were collected during the first three months of life and at weaning. Parasitological analyses were performed according to standard procedures including specifically the detection of Eimeria spp., Cryptosporidium parvum, Strongyloides papillosus and Trichostrongylida. The effects of an infection with endoparasites on weight gain were analyzed with a linear model accounting for effects of farm, breed, sex, calving month and weight at birth. The average prevalences of endoparasites within the first three months of life were: E. bovis 36%, E. zuernii, 19%, C. parvum 16.8%, S. papillosus 22.3% and Trichostrogylida 1.5%. The prevalence of diarrhea within the same time period was 13%. Prevalences at weaning (at the end of the grazing period) were: E. bovis 56.5%, E. zuernii 4.6%, C. parvum 3.7%, S. papillosus 14.4% and Trichostrogylida 84.5%. With the exception of E. zuernii, endoparasites were more frequently observed in healthy calves than in diarrheic calves. Weaning weights were available from 190 calves (33 herds). Statistical analyses of weaning weights revealed no evidence that an infection with helminths and/or protozoa within the first three months of life or at weaning had a negative influence on individual weight gain

Dysphagia due to triple A syndrome: successful treatment of achalasia by balloon dilatation

Triple A syndrome is a rare autosomal recessive inherited disorder which is characterized by alacrima, adrenal insufficiency, and achalasia. We report on a 14-year old girl with dysphagia, regurgitation, and vomiting since 5 years. At the age of five years an Addison crisis was diagnosed and cortisone substitution was initiated. In addition, the patient had episodes of conjunctivitis. Severe esophagitis and candida infection were diagnosed by esophago-gastro-duodenoscopy and treated with omeprazole and fluconazole. The esophageal barium swallow was typical for achalasia. Medical treatment of achalasia with oral nifedipine resulted only in a partial and temporal improvement. But after seven balloon dilatations dysphagia and nocturnal coughing improved clearly and a remarkable gain of weight could be seen. Direct sequencing showed a homozygous nonsense mutation in exon 11 of the AAAS gene leading to truncation at position 342 of the 546 amino acid protein. CONCLUSION: Triple A syndrome has to be considered in patients with dysphagia. In our patient, the absence of tears since birth followed by adrenal insufficiency were early signs of the triple A syndrome. Balloon dilatation of the esophago-gastric junction is an effective treatment, which can avoid surgical interventions

N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase : a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides

Particulate fractions of human small intestinal mucosa contain an enzyme capable of hydrolyzing N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA-peptide), a substrate used for clinical purposes to assess exocrine function of the pancreas (PABA test, pancreas function test). In this paper we describe the purification of PABA-peptide hydrolase (PPH) by immunoaffinity chromatography using a monoclonal antibody (Mab), HBB 3/716/36, bound to protein A-Sepharose, and the characterization of the purified enzyme. The final preparation of the enzyme was in the immobilized form, i.e., bound to Mab-protein A-Sepharose, and showed a 765-fold enrichment over the mucosal homogenate. The enrichment factor in purified microvillus membranes was comparable to that of sucrase-isomaltase, a microvillar marker enzyme. This, together with immunoelectron microscopy using protein A-gold, indicated that PPH is located in the apical membrane of intestinal epithelial cells. The enzyme was found to be present throughout the small intestine with the activity in distal ileum being 4.5-fold higher than that in the proximal duodenum. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the immunoaffinity-purified PPH under reducing conditions revealed a polypeptide band with a relative molecular weight (Mr) of 100,000; under nonreducing conditions a major band with Mr 200,000 was observed. This indicates that PPH consists of two subunits with Mr 100,000 each, which are held together by one or more disulfide bonds. Two-dimensional polyacrylamide gel electrophoresis of the enzyme showed marked microheterogeneity, with pI's ranging from 6.0 to 6.85, probably due to glycosylation. The Km for PABA-peptide was 16.7 mM, and the pH optimum was 7.5-8.0 PPH activity was not inhibited by phenylmethylsulfonyl fluoride; pepstatin, leupeptin, amastatin, bestatin, puromycin, iodoacetate, or phosphoramidon. Activity was affected by captopril and Zinkov inhibitor, and in particular by thiol and chelating reagents. Chelator-inhibited PPH could be reactivated by bivalent metal ions, Zn2+ being the most effective. The enzyme catalyzed the hydrolysis of peptides including insulin B-chain, angiotensins I and II, bradykinin and bradykinin derivatives, oxytocin, and substance P, in each case yielding reproducible peptide fragments. On the basis of amino acid analysis of the products it could be concluded that peptides are hydrolyzed preferentially after an aromatic residue

Malnutrition and diarrhea: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition.

Journal Articleinfo:eu-repo/semantics/publishe